Abstract
The neutral red uptake assay is a cell viability assay that allows in vitro quantification of xenobiotic-induced cytotoxicity. The assay relies on the ability of living cells to incorporate and bind neutral red, a weak cationic dye, in lysosomes. As such, cytotoxicity is expressed as a concentration-dependent reduction of the uptake of neutral red after exposure to the xenobiotic under investigation. The neutral red uptake assay is mainly used for hazard assessment in in vitro toxicology applications. This method has also been introduced in regulatory recommendations as part of 3T3-NRU-phototoxicity-assay, which was regulatory accepted in all EU member states in 2000 and in the OECD member states in 2004 as a test guideline (TG 432). The present protocol describes the neutral red uptake assay using the human hepatoma cell line HepG2, which is often employed as an alternative in vitro model for human hepatocytes. As an example, the cytotoxicity of acetaminophen and acetyl salicylic acid is assessed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Borenfreund E, Puerner J (1984) A simple quantitative procedure using monolayer cultures for cytotoxicity assays (HTD/NR90). J Tissue Cult Methods 9(1):7–9
Repetto G, del Peso A, Zurita JL (2008) Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat Protoc 3(7):1125–1131
Zuang V (2001) The neutral red release assay: a review. Altern Lab Anim 29(5):575–599
Rodrigues RM, Bouhifd M, Bories G, Sacco M, Gribaldo L, Fabbri M, Coecke S, Whelan MP (2013) Assessment of an automated in vitro basal cytotoxicity test system based on metabolically-competent cells. Toxicol In Vitro 27(2):760–767
The National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (2003) Test method protocol for the BALB/c 3T3 neutral red uptake cytotoxicity test. A test for basal cytotoxicity for an in vitro validation study phase III. https://ntp.niehs.nih.gov/iccvam/methods/acutetox/invidocs/phiiiprot/3t3phiii.pdf. Accessed Jun 2016
Organisation for Economic Co-operation and Development (2004) Guideline 432: in vitro 3T3 NRU phototoxicity test. OECD guidelines for the testing of chemicals. http://www.oecd-ilibrary.org/environment/test-no-432-in-vitro-3t3-nru-phototoxicity-test_9789264071162-en. Accessed Jun 2016
European Commission Joint Research Center (2013) EURL ECVAM recommendation on the 3T3 neutral red uptake (3T3 NRU) cytotoxicity assay for the identification of substances not requiring classification for acute oral toxicity. https://eurl-ecvam.jrc.ec.europa.eu/eurl-ecvam-recommendations/3t3-nru-recommendation. Accessed Jun 2016
Bouhifd M, Bories G, Casado J, Coecke S, Norlén H, Parissis N, Rodrigues RM, Whelan MP (2012) Automation of an in vitro cytotoxicity assay used to estimate starting doses in acute oral systemic toxicity tests. Food Chem Toxicol 50(6):2084–2096
Knowles BB, Aden DP (1983) Human hepatoma derived cell line, process for preparation thereof, and uses therefor. US Patent 4,393,133
Schoonen WG, Westerink WM, de Roos JA, Débiton E (2005) Cytotoxic effects of 100 reference compounds on HepG2 and HeLa cells and of 60 compounds on ECC-1 and CHO cells. I mechanistic assays on ROS, glutathione depletion and calcein uptake. Toxicol In Vitro 19(4):505–516
Chiu JH, Hu CP, Lui WY, Lo SJ, Chang CM (1990) The formation of bile canaliculi in human hepatoma-cell lines. Hepatology 11:834–842
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Ates, G., Vanhaecke, T., Rogiers, V., Rodrigues, R.M. (2017). Assaying Cellular Viability Using the Neutral Red Uptake Assay. In: Gilbert, D., Friedrich, O. (eds) Cell Viability Assays. Methods in Molecular Biology, vol 1601. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6960-9_2
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6960-9_2
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6959-3
Online ISBN: 978-1-4939-6960-9
eBook Packages: Springer Protocols